Biased recall of pandemic perceptions and behaviors in study 1. Results of a linear regression predicting the individual recall of past perceptions on the basis of actual past ratings (x axis) in 2020–2021 and present ratings (y axis) in late 2022, as well as interactions with vaccination status (colors) and vaccination status identification (VSI; dashed …
Patient and spell characteristics. (A) Distribution of age at onset and age at diagnosis of breath-holding spells in our cohort. (B) Overview of the semiology of the spells. One patient could have more than one type of semiology in different spells or in one spell, shown here as overlap. (C) Overview of heredity in relation …
Children with breath-holding spells undergo unnecessary diagnostic interventions: Study Read More »
Credit: Anna Shvets from Pexels Dental professionals can make a marked and positive difference to public health by being trained to spot some of the key markers of chronic disease, according to new research. The study, titled “Opportunistic health screening for cardiovascular and diabetes risk factors in primary care dental practices: experiences from a service …
Credit: Cell Stem Cell (2023). DOI: 10.1016/j.stem.2023.10.007 Researchers from multiple institutions in China have found a way to use gene editing to reactivate dormant fetal oxygen-transporting proteins in adult blood cells to potentially reverse a wide range of blood disorders. In a paper, “Base editing of the HBG promoter induces potent fetal hemoglobin expression with …
Reactivating silenced fetal hemoglobin genes could counter sickle cell–related diseases Read More »
10 May 2023 | 09:59 AM Europe/Amsterdam Not intended for U.S. and UK Media Summary Global phase III QUASAR study will assess the efficacy and safety of aflibercept 8 mg in macular edema secondary to retinal vein occlusion (RVO) / Study comes after positive data from the phase III PULSAR trial in neovascular (wet) age-related …
Leverkusen/Kyiv, April 5, 2023 – Bayer has revealed an investment of overall 60 million euros from 2023 onwards in its corn seed production facility Pochuiky, Ukraine. With this the life sciences company emphasizes its commitment to Ukraine and strengthens its Crop Science business in the country, contributing to rebuilding the economy. This investment includes a …
Bayer to invest a total of 60 million euros in its Ukrainian seed production site Read More »
Leverkusen, April 3, 2023 – Bayer AG has established a Bioethics Council consisting of internationally renowned experts, to provide broad independent perspective and guidance on current bioethical questions, particularly with regard to the development of new biotechnological and artificial intelligence based solutions. Bayer is committed to using emerging technologies in an ethically responsible way as …
Leverkusen, March 21, 2023 – Bayer is launching its new water strategy at the UN 2023 Water Conference in New York. The company is making water an integral part of its business decisions, investments and selection of suppliers. Bayer’s water strategy reflects its position as a key player in the fields of health and agriculture …
Bayer pledges to help tackle global water crisis with new water strategy Read More »
Not intended for U.S. and UK Media Berlin, March 20, 2023 – The Chinese National Medical Products Administration (NMPA) has approved the oral androgen receptor inhibitor (ARi) Nubeqa™ (darolutamide) in combination with docetaxel for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC). Nubeqa is already approved in China for the treatment of patients …
Nubeqa™ (darolutamide) approved for additional prostate cancer indication in China Read More »
In this MedPage Today video, Lakshi Aldredge, MSN, ANP-BC, DCNP, of VA Portland Health Care System in Oregon, hypothesizes how the management of atopic dermatitis and our understanding of the condition will change over time. Following is a transcript of her remarks: If I had a crystal ball and looked at 2024, what we’re also …